0 NASDAQ Companies - September 3, 2024UPDATE — Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2024PRINCETON, N.J., Sept. 03, 2024 (GLOBE NEWSWIRE) — Amicus Therapeutics (Nasdaq: FOLD) today announced that management will participate in upcoming […]Read More
0 NASDAQ Companies - September 3, 2024Affimed Appoints Shawn M. Leland as Chief Executive OfficerMANNHEIM, Germany, Sept. 03, 2024 (GLOBE NEWSWIRE) — Affimed N.V. (Nasdaq: AFMD) (“Affimed” or the “Company”), a clinical-stage immuno-oncology company […]Read More
0 NASDAQ Companies - September 3, 2024Maris-Tech Receives U.S. Patent for Innovative Forward Error Correction Optimization MethodThe patented method reduces overhead data required in the forward error correction process based on specific characteristics of streamed media […]Read More
0 NYSE Companies - September 3, 2024NCL Corporation Ltd. Announces Proposed Offering of Senior NotesMIAMI, Sept. 03, 2024 (GLOBE NEWSWIRE) — NCL Corporation Ltd. (“NCLC”), a subsidiary of Norwegian Cruise Line Holdings Ltd. (NYSE: […]Read More
0 NASDAQ Companies - September 3, 2024H World Group Limited Announces Change of Chief Financial OfficerSINGAPORE and SHANGHAI, Sept. 03, 2024 (GLOBE NEWSWIRE) — H World Group Limited (NASDAQ: HTHT and HKEX: 1179) (“H World” […]Read More
0 NYSE Companies - September 3, 2024Forensic Accounting and Litigation Expert Juli Saitz Joins FTI Consulting as Senior Managing DirectorWASHINGTON, Sept. 03, 2024 (GLOBE NEWSWIRE) — FTI Consulting, Inc. (NYSE: FCN) today announced the appointment of Juli Saitz as […]Read More
0 NASDAQ Companies - September 3, 2024Ocugen to Participate in a Fireside Chat at the H.C. Wainwright 26th Annual Global Investment ConferenceMALVERN, Pa., Sept. 03, 2024 (GLOBE NEWSWIRE) — Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused […]Read More
0 NASDAQ Companies - September 3, 2024MiNK Therapeutics to Participate in H.C. Wainwright Global Investment ConferenceNEW YORK, Sept. 03, 2024 (GLOBE NEWSWIRE) — MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering the discovery, development, […]Read More
0 TSX Venture News - September 3, 2024First Helium Reminds Participants of Webinar to Present High Impact Exploration Targets for Fall of 2024CALGARY, Alberta, Sept. 03, 2024 (GLOBE NEWSWIRE) — First Helium Inc. (“First Helium” or the “Company”) (TSXV: HELI) (OTCQB: FHELF) […]Read More
0 TSX Venture News - September 3, 2024Skyharbour Commences Summer Diamond Drilling Program at its Moore Uranium Project, SaskatchewanVancouver, BC, Sept. 03, 2024 (GLOBE NEWSWIRE) — Skyharbour Resources Ltd. (TSX-V:SYH) (OTCQX:SYHBF) (Frankfurt:SC1P) (the “Company”) is pleased to announce that […]Read More